CN111411137B - Method for synthesizing 8-methoxyl coumarin-3-carboxylic acid-6' -O-D-glucose ester on line under catalysis of lipase - Google Patents
Method for synthesizing 8-methoxyl coumarin-3-carboxylic acid-6' -O-D-glucose ester on line under catalysis of lipase Download PDFInfo
- Publication number
- CN111411137B CN111411137B CN202010132118.5A CN202010132118A CN111411137B CN 111411137 B CN111411137 B CN 111411137B CN 202010132118 A CN202010132118 A CN 202010132118A CN 111411137 B CN111411137 B CN 111411137B
- Authority
- CN
- China
- Prior art keywords
- reaction
- glucose
- carboxylic acid
- methoxycoumarin
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/605—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin to a 1-benzopyran-2-on (or the chalcones and hydrogenated chalcones thereof, e.g. coumermycin, novobiocin, novenamin)
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0093—Microreactors, e.g. miniaturised or microfabricated reactors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/18—Apparatus specially designed for the use of free, immobilized or carrier-bound enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/16—Microfluidic devices; Capillary tubes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/40—Manifolds; Distribution pieces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/12—Means for regulation, monitoring, measurement or control, e.g. flow regulation of temperature
- C12M41/18—Heat exchange systems, e.g. heat jackets or outer envelopes
- C12M41/22—Heat exchange systems, e.g. heat jackets or outer envelopes in contact with the bioreactor walls
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Sustainable Development (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Clinical Laboratory Science (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
A method for synthesizing 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester on line by lipase catalysis comprises the following steps: uniformly filling lipase RM IM in a reaction channel of a microfluidic channel reactor, dissolving 8-methoxycoumarin-3-carboxylic acid methyl ester and D-glucose respectively by using a reaction solvent, respectively injecting the dissolved 8-methoxycoumarin-3-carboxylic acid methyl ester and D-glucose into a pipeline through a first injector and a second injector for integration, then entering the reaction channel for reaction, controlling the reaction temperature to be 30-60 ℃, controlling the continuous flowing reaction time of mixed solution in the reaction channel to be 10-60 min, collecting the reaction solution flowing out of the reaction channel on line through a product collector, and performing aftertreatment to obtain a product 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester (I); the method has the advantages of short reaction time, high yield and good selectivity.
Description
Technical Field
The invention relates to a method for synthesizing 8-methoxy coumarin-3-carboxylic acid-6' -O-D-glucose ester on line by lipase catalysis.
Background
Coumarin is a basic structural subunit of a variety of plant secondary and microbial metabolites, and has a range of attractive biological activities including antibacterial, anticoagulant, antiviral, antitubercular, antioxidant, and antitumor activities. Several natural synthetic drugs containing coumarin scaffolds, such as warfarin as an anticoagulant for vitamin K antagonists, have been used clinically and widely in thrombosis treatment, and the common antibiotics, armillaria mellea a and novobiocin, both contain coumarin subunits. In addition, due to the parent structure of coumarin, it is widely used in the fields of specific fluorescent probes, dyes, fluorescent imaging, and the like. Among them, the synthesis of coumarin derivatives containing saccharide branches has attracted considerable attention in organic and pharmaceutical research and development. The interesting point of the coumarin containing saccharides is that these compounds have good water solubility. These results can improve the physicochemical, biopharmaceutical and pharmacokinetic properties of the drug. The study by sorsen et al showed that glycosylation of warfarin caused a shift from anticoagulant to anticancer activity, and they demonstrated that glycosylation of warfarin could show 70-fold higher anticancer activity than the original compound. This study clearly demonstrates that additional sugars are critical to altering the mechanism of action and potency of coumarin parent drugs. Over the past several years, several studies have been reported on coumarin containing sugars. Su Pulan et al synthesized a series of glycosyl coumarin carbonic anhydrase IX and XII inhibitors, which have strong inhibition effect on the growth of primary breast tumors. In 2016, nilsson et al reported a selective galectin-3 inhibitor, a coumarin derivative, which showed similar effects to the known non-selective galectin-1/galectin-3 inhibitor in a mouse model of bleomycin-induced pulmonary fibrosis.
The construction of sugar-containing derivatives can be achieved by basic synthetic methods, the most common synthetic strategy being chemical. The specific active hydroxyl groups on the saccharides are selectively synthesized by a "protection" or "protection deprotection" step. Visible light has also recently been reported as a glycosylation catalyst, however, most schemes for light-induced glycosylation require a transition metal catalyst in combination with expensive additives or oxidants to perform the reaction. Thus, the introduction of sugar chemically is still limited by the disadvantages of poor regio-and stereoselectivity, lengthy protection and deprotection of functional groups.
Biocatalysts have attracted considerable attention from chemists and biochemists as an efficient green bioconversion tool in organic synthesis. Particularly, the catalytic compounding in biocatalysis, namely, the old enzyme is utilized to form a new bond and follow a new path, so that the method has extremely and rapidly expanded. Some enzymes, such as engineered C-glycosyltransferase (micgtb-gagm), have been used in the synthesis of coumarin C-glycosides, where both C-glucosides synthesized have strong SGLT2 inhibitory activity. The enzyme-catalyzed reaction is relatively mild, green, but requires a long reaction time (typically as long as 24 hours or more) to achieve the desired result, and some rely on expensive enzymes. In recent years, continuous flow microreactors have become an effective way to shorten reaction time and increase yield by enzyme coupling.
Modern synthetic chemistry faces challenges in providing society with high performance, environmental protection, low cost, safety, and atomic efficiency valuable products. In this regard, continuous flow microreactor technology (MRT) is becoming increasingly popular as a replacement for traditional batch chemical synthesis. In particular, with respect to the 12-element principle of green chemistry, MRT can play a major role in improving chemical processes. The high surface to volume ratio of the microreactor means results in better heat exchange and efficient mixing, thus increasing the reaction efficiency. Furthermore, MRT systems have at the beginning of science involved reaction scales that allow efficient on-demand production of compounds in compact, reconfigurable equipment. In this case, "outwardly expanded" or "upwardly numbered" refers to a continuous flow system array operating in parallel to meet the desired output. Flow chemistry, particularly catalyst/substrate conditions in continuous flow systems, can improve reactivity and selectivity. At the same time, when the continuous flow column is filled with heterogeneous catalyst, separation of catalyst and product is very easy. In order to explore a new, eco-friendly and efficient scheme of the coumarin containing sugar and as part of our ongoing development research of the novel coumarin containing drug, we have found a method for synthesizing 8-methoxycoumarin-3-carboxylic acid-6 '-O-D-glucose ester on line by lipase catalysis in a microchannel reactor, aiming at finding an efficient and environment-friendly on-line controllable selective synthesis method of 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester.
Disclosure of Invention
The invention aims to provide a novel process method for synthesizing 8-methoxy coumarin-3-carboxylic acid-6' -O-D-glucose ester on line by lipase catalysis in a microfluidic channel reactor, which has the advantages of short reaction time, high yield and good selectivity.
The technical scheme of the invention is as follows:
a method for synthesizing 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester on line by lipase catalysis comprises the following steps:
uniformly filling lipase RM IM (catalyst) into a reaction channel of a microfluidic channel reactor, dissolving 8-methoxycoumarin-3-carboxylic acid methyl ester and D-glucose respectively by using a reaction solvent, respectively injecting the dissolved 8-methoxycoumarin-3-carboxylic acid methyl ester and D-glucose into a pipeline through a first injector and a second injector for integration, then entering the reaction channel for reaction, controlling the reaction temperature to be 30-60 ℃ (preferably 35 ℃), controlling the continuous flowing reaction time of a mixed solution in the reaction channel to be 10-60 min (preferably 40 min), collecting the reaction solution flowing out of the reaction channel on line through a product collector, and performing post-treatment to obtain a product 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester (I);
the reaction solvent is a mixed solvent of dimethyl sulfoxide and tertiary amyl alcohol, wherein the volume ratio of dimethyl sulfoxide to tertiary amyl alcohol is 1:8 to 20, preferably 1:18;
the ratio of the amounts of the substances of 8-methoxy coumarin-3-carboxylic acid methyl ester and D-glucose in the mixed solution entering the reaction channel is 1:0.2 to 3, preferably 1:0.25, the specific operation can be as follows: after the 8-methoxycoumarin-3-carboxylic acid methyl ester and the D-glucose are respectively dissolved by using a reaction solvent, the mass concentration ratio of the substances of the obtained 8-methoxycoumarin-3-carboxylic acid methyl ester solution and the D-glucose solution is 1:0.2 to 3, preferably 1:0.25; the flow rates of the 8-methoxycoumarin-3-carboxylic acid methyl ester solution and the D-glucose solution are the same when the 8-methoxycoumarin-3-carboxylic acid methyl ester solution and the D-glucose solution are injected through a first injector and a second injector respectively;
the lipase RM IM is commercially available, for example from Novozymes corporation, which is a preparation of 1, 3-position specific, food grade lipase (EC 3.1.1.3) on granular silica gel prepared from microorganisms produced by submerged fermentation with a genetically modified Aspergillus oryzae (Aspergillus oryzae) microorganism, obtained from Rhizomucor miehei; the lipase RM IM can be obtained by directly and uniformly fixing a granular catalyst in a reaction channel through a physical method; the catalyst is added in an amount of 0.025-0.05 g/mL based on the volume of the reaction medium within the maximum limit of the reaction channel capable of accommodating the filled catalyst;
the post-treatment method comprises the following steps: the solvent was removed by distillation under reduced pressure from the reaction mixture, and the mixture was subjected to column chromatography on a silica gel column, and the column was packed with 200-300 mesh silica gel by wet method, with the volume ratio of dichloromethane and methanol=10: 1.5, collecting the eluent containing the target compound by TLC tracking the elution process, evaporating the solvent and drying to obtain the product 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester (I);
the synthesis method adopts a microfluidic channel reactor, and the microfluidic channel reactor comprises the following steps: a first syringe, a second syringe, a reaction channel, and a product collector; the first injector and the second injector are connected with the inlet of the reaction channel through Y-shaped or T-shaped pipelines, and the product collector is connected with the outlet of the reaction channel through a pipeline;
further, the method comprises the steps of,
the inner diameter of the reaction channel is 0.8-2.4 mm, and the length of the reaction channel is 0.5-1.0 m;
the first injector and the second injector are arranged in the injection pump, and are synchronously pushed by the injection pump, and the specification of the first injector is consistent with that of the second injector;
the microfluidic channel reactor also comprises an incubator, wherein the reaction channel is arranged in the incubator, so that the reaction temperature can be effectively controlled, and the incubator can be selected according to the reaction temperature requirement, such as a water bath incubator and the like;
the material of the reaction channel is not limited, and green and environment-friendly materials such as silicone tubes are recommended; the shape of the reaction channel is preferably curved, so that the reaction liquid can pass through the reaction channel stably at a constant speed.
Compared with the prior art, the invention has the beneficial effects that:
the method utilizes lipase to catalyze and synthesize 8-methoxy coumarin-3-carboxylic acid-6' -O-D-glucose ester on line in the microfluidic channel reactor, so that the method not only greatly shortens the reaction time, but also has high conversion rate and selectivity; meanwhile, the method utilizes the economic lipase RM IM to catalyze the reaction of 8-methoxy coumarin-3-carboxylic acid methyl ester and D-glucose for the first time, reduces the reaction cost, and has the advantages of economy and high efficiency.
Drawings
Fig. 1 is a schematic structural diagram of a microfluidic channel reactor according to an embodiment of the present invention.
In the figure, a 1-first syringe, a 2-second syringe, a 3-reaction channel, a 4-product collector and a 5-water bath incubator.
Detailed Description
The invention is further illustrated by the following examples, but the scope of the invention is not limited thereto:
the structure of the microfluidic channel reactor used in the embodiment of the present invention is shown in fig. 1, and includes an injection pump, a first injector 1, a second injector 2, a reaction channel 3, a water bath incubator 5 (only a schematic plan view thereof is shown), and a product collector 4; the first injector 1 and the second injector 2 are arranged in an injection pump and are connected with the inlet of a reaction channel 3 through a Y-shaped interface, the reaction channel 3 is arranged in a water bath constant temperature box 5, the reaction temperature is controlled through the water bath constant temperature box 5, the inner diameter of the reaction channel 3 is 2.0mm, the tube length is 1.0m, and the outlet of the reaction channel 3 is connected with a product collector 4 through an interface.
Example 1: synthesis of 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester
The apparatus is described with reference to fig. 1: methyl 8-methoxycoumarin-3-carboxylate (2.0 mmol) was dissolved in 0.52mL of dimethyl sulfoxide and 9.48mL of t-amyl alcohol, and D-glucose (0.5 mmol) was dissolved in 0.52mL of dimethyl sulfoxide and 9.48mL of t-amyl alcohol, and then separately filled into 10mL syringes for use. 0.87g lipase RM IM is uniformly filled in the reaction channel, and under the pushing of PHD 2000 injection pump, two reaction solutions are respectively filled with 7.8 mu Lmin -1 The reaction is carried out by the flow rate of the reaction liquid entering the reaction channel through the Y joint, the temperature of the reactor is controlled to be 35 ℃ through a water bath constant temperature box, the reaction liquid flows in the reaction channel for 40min, and the reaction result is tracked and detected through thin layer chromatography TLC.
Collecting reaction liquid on line through a product collector, distilling under reduced pressure to remove solvent, loading into a column by using 200-300 mesh silica gel wet method, eluting with dichloromethane: methanol=10:1.5, column height of 35cm, column diameter of 4.5cm, dissolving sample with a small amount of eluting reagent, loading into the column by wet method, and collecting eluent with flow rate of 2 mL.min -1 Simultaneously, TLC tracks the elution progress, and the obtained eluates containing single products are combined and evaporated to dryness to obtain light yellow solid, so as to obtain 8-methoxycoumarin-3-carboxylic acid-6 '-O-D-glucose ester, and the conversion rate of the 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester is detected by HPLC and is 63% and the selectivity is 99%.
The nuclear magnetic characterization results were as follows:
1 H NMR(DMSO-d 6 ,500MHz,δ,ppm)8.67(s,0.5H,H-4ofβ-D-glucose),8.65(s,0.5H,H-4ofα-D-glucose),7.45-7.39(m,2H,H-5,H-7),7.33(t,J＝7.9Hz,1H,H-6),6.72(s,0.5H,C1′-OH ofβ-D-glucose),6.39(s,0.5H,C1′-OH ofα-D-glucose)5.35-4.78(m,3H,C1′-H of D-glucose,C4′-OH ofD-glucose,C2′-OH ofβ-D-glucose),4.70-4.47(m,1.5H,C3′-OH ofα-D-glucose,C6′-Ha of D-glucose),4.36(d,J＝7.7Hz,0.5H,C3′-OH ofβ-D-glucose),4.30(td,J＝12.1,6.2Hz,1H,C6′-Hb of D-glucose),3.92(s,3H,H-12),3.91(s,0.5H,C5′-H ofα-D-glucose),3.51-3.47(m,1H,C5′-H ofβ-D-glucose,C3′-Hofα-D-glucose),3.24-3.18(m,2H,C2′-H of D-glucose,C3′-H ofβ-D-glucose,C4′-H ofα-D-glucose),2.97(t,J＝8.2Hz,0.5H,C4′-H ofβ-D-glucose). 13 C NMR(126MHz,DMSO)δ162.53,162.49(C-11),155.67(C-2),148.93,148.81(C-8),146.26(C-9),143.92(C-4),124.84(C-6),121.16(C-5),118.23(C-3),117.79,117.72(C-7),116.51(C-10),97.02(C1′ofβ-D-glucose),92.41(C1′ofα-D-glucose),76.46(C3′ofβ-D-glucose),74.72(C2′ofβ-D-glucose),73.50(C5′ofβ-D-glucose),72.91(C3′ofα-D-glucose),72.18(C2′ofα-D-glucose),70.59(C4′ofα-D-glucose),70.19(C4′ofβ-D-glucose),69.21(C5′ofα-D-glucose),65.26(C6′of D-glucose),56.21,56.17(C-12).
examples 2 to 8
The volume ratio of reaction medium DMSO to tertiary amyl alcohol in the microfluidic channel reactor was changed, the substrate ratio of 8-methoxycoumarin-3-carboxylic acid methyl ester to D-glucose was 2:1 (1.0 mmol:0.5 mmol), the control temperature was 50 ℃, the reaction time was 30min, the other same as in example 1, and the reaction results are shown in Table 1:
TABLE 1 influence of the volume ratio of DMSO to t-amyl alcohol in the reaction Medium on the reaction
| Examples | DMSO: tert-amyl alcohol | Conversion [%] | Selectivity [%] |
| 2 | 1:8 | n.d. | / |
| 3 | 1:10 | 15％ | 99％ |
| 4 | 1:12 | 26％ | 99％ |
| 5 | 1:14 | 34％ | 99％ |
| 6 | 1:16 | 39％ | 99％ |
| 7 | 1:18 | 44％ | 99％ |
| 8 | 1:20 | 42％ | 99％ |
The results in Table 1 show that when the substrate molar ratio of reactant methyl 8-methoxycoumarin-3-carboxylate to D-glucose is 2:1, the flow rate is 10.4. Mu.L.min -1 The reaction time is 30min, when the reaction temperature is 50 ℃, the conversion rate of the reaction is increased along with the increase of the volume ratio of the tertiary amyl alcohol in the reaction medium, and when the volume ratio of the DMSO in the reaction medium to the tertiary amyl alcohol is 1:18, the conversion rate of the reaction is optimal, and at the moment, if the volume ratio of the tertiary amyl alcohol is continuously increased, the dissolution amount of sugar in the reaction medium is reduced, so that the conversion rate of the reaction is reduced. The optimal reaction medium volume ratio for this reaction in the microfluidic microchannel reactor of the invention is thus DMSO: t-amyl alcohol=1:18.
Examples 9 to 15
The molar ratio of 8-methoxycoumarin-3-carboxylic acid methyl ester to D-glucose substrate in the microfluidic microchannel reactor was changed, the reactor temperature was controlled at 50℃and the reaction time was 30min, and the results were as shown in Table 2, except for example 1:
TABLE 2 influence of the ratio of the amounts of methyl 8-methoxycoumarin-3-carboxylate and D-glucose substrate substances on the reaction
The results in Table 2 show that the volume ratio of the reaction medium DMSO to t-amyl alcohol is 1:18, the flow rate is 10.4. Mu.L.min -1 The reaction time is 30min, the reaction conversion rate is increased along with the increase of the reactant 8-methoxy coumarin-3-carboxylic acid methyl ester when the reaction temperature is 50 ℃, and the reaction conversion rate is optimal when the substrate ratio is 4:1, and the reaction conversion rate is reduced if the use amount of the reactant 8-methoxy coumarin-3-carboxylic acid methyl ester is continuously increased. The optimal substrate molar ratio for this reaction in the microfluidic microchannel reactor of the invention is thus 8-methoxycoumarin-3-carboxylic acid methyl ester to D-glucose=4:1.
Examples 16 to 22
The temperature of the microfluidic channel reactor was varied and the reaction time was controlled to 30min, otherwise the same as in example 1, and the reaction results are shown in table 3:
table 3: influence of temperature on the reaction
| Examples | Temperature [ DEGC] | Conversion [%] | Selectivity [%] |
| 16 | 30℃ | 55％ | 98％ |
| 17 | 35℃ | 59％ | 99％ |
| 18 | 40℃ | 57％ | 99％ |
| 19 | 45℃ | 53％ | 98％ |
| 20 | 50℃ | 50％ | 97％ |
| 21 | 55℃ | 46％ | 94％ |
| 22 | 60℃ | 42％ | 90％ |
The results in Table 3 show that when the volume ratio of DMSO to t-amyl alcohol in the reaction medium is 1:18, the substrate molar ratio of methyl 8-methoxycoumarin-3-carboxylate to D-glucose is 4:1, and the flow rate is 10.4. Mu.L.min -1 When the reaction time is 30min, the conversion rate of the reaction is optimal when the reaction temperature is 35 ℃, and the activity of the enzyme is affected by the temperature which is too high or too low. The optimum reaction temperature for this reaction in the microfluidic microchannel reactor of the invention is 35 ℃.
Examples 23 to 27
The reaction time of the microfluidic channel reactor was varied, and the reaction results are shown in table 4, except for example 1:
table 4: effect of reaction time on reaction
| Examples | Time [ min] | Conversion [%] | Selectivity [%] |
| 23 | 10 | 41％ | 99％ |
| 24 | 20 | 51％ | 99％ |
| 25 | 30 | 59％ | 99％ |
| 1 | 40 | 63％ | 99％ |
| 26 | 50 | 61％ | 98％ |
| 27 | 60 | 57％ | 94％ |
The results in Table 4 show that when the volume ratio of DMSO to t-amyl alcohol is 1:18, the substrate molar ratio of methyl 8-methoxycoumarin-3-carboxylate to D-glucose is 4:1, and the reaction temperatures are 35 ℃, the flow rate is 7.8. Mu.L.min -1 When the reaction time is up to 40min, the reaction conversion rate can reach 63%, and if the reaction time is prolonged, the reaction conversion rate is reduced. Thus, the optimal reaction time for this reaction in a microfluidic channel reactor was 40min.
Comparative examples 1 to 3
The catalysts in the microfluidic microchannel reactor were changed to porcine pancreatic lipase PPL (comparative example 1), lipase Novozym435 (comparative example 2), and subtilisin (comparative example 3), respectively, and the results are shown in table 5.
Table 5: influence of different enzymes on reaction conversion and selectivity
| Comparative example | Enzyme source | Conversion [%] | Selectivity [%] |
| 1 | PPL | 18％ | 64％ |
| 2 | Novozym 435 | 33％ | 73％ |
| 3 | Bacillus subtilis alkaline protease | 0 | 0 |
| Example 1 | Lipozyme RM IM | 63％ | 99％ |
The results in Table 5 show that for the regioselective transesterification of methyl 8-methoxycoumarin-3-carboxylate with D-glucose in a microfluidic reactor, different enzymes have a very pronounced effect on the reaction. The conversion rate is 18% by utilizing the catalytic reaction of porcine pancreatic lipase PPL; catalyzing the reaction by using bacillus subtilis alkaline protease, wherein the conversion rate is 0%; the reaction was catalyzed with Novozym435 with a conversion of 33%. From the results in Table 5, the most efficient catalyst for the regioselective transesterification of methyl 8-methoxycoumarin-3-carboxylate with D-glucose in a microfluidic reactor was lipase RM IM with a conversion of 63% and a selectivity of 99%.
Comparative examples 4 to 6
The reaction materials in the microfluidic microchannel reactor were changed, the acyl donor was changed to tert-butyl 8-methoxycoumarin-3-carboxylate (comparative example 4), the acyl acceptor was changed to D-galactose (comparative example 5), and the acyl donor and acyl acceptor (comparative example 6) were simultaneously changed, and the results are shown in table 6, except for example 1.
TABLE 6 influence of different enzymes on reaction conversion and selectivity
| Comparative example | Acyl donor | Acyl acceptors | Conversion [%] | Selectivity [%] |
| 4 | 8-Methoxycoumarin-3-carboxylic acid tert-butyl ester | D-glucose | 13％ | 73％ |
| 5 | 8-methoxy incenseSoyabean extract-3-carboxylic acid methyl ester | D-galactose | 15％ | 58％ |
| 6 | 8-Methoxycoumarin-3-carboxylic acid tert-butyl ester | D-galactose | 0 | 0 |
| Example 1 | 8-Methoxycoumarin-3-carboxylic acid methyl ester | D-glucose | 63％ | 99％ |
The results in Table 6 show that for the regioselective transesterification synthesis of the enzymatic 8-methoxycoumarin-3-carboxylic acid sugar ester in a microfluidic reactor, the different substrates have a very pronounced effect on the reaction. Using 8-methoxycoumarin-3-carboxylic acid tert-butyl ester as acyl donor, and using D-glucose as acyl acceptor, the conversion rate is 13%; using 8-methoxy coumarin-3-carboxylic acid methyl ester as acyl donor, using D-galactose as acyl acceptor, and converting 15%; the conversion rate is 0% by using 8-methoxycoumarin-3-carboxylic acid tert-butyl ester as acyl donor and D-galactose as acyl acceptor. From the results of table 6, the tert-butyl 8-methoxycoumarin-3-carboxylate is not an effective acyl donor and the D-galactose is not an effective acyl acceptor for the regioselective transesterification synthesis of the enzymatic 8-methoxycoumarin-3-carboxylate in a microfluidic reactor.
Application example 1
Determination of 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester on Staphylococcus aureus by oxford cup methodThe size of the bacteriostasis zone of the staphylococcus. 100. Mu.L of test bacteria solution (concentration of bacteria solution 1X 10) was added to the nutrient agar plate 7 CFU/mL), uniformly coating the bacterial liquid by using a sterile coater; 3 oxford cups are placed on the surface of the culture medium at equal distance and are pressed lightly, so that the oxford cups are contacted with the culture medium; adding 200 μl (concentration 1 g/mL) of 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester into the cup, and repeating for 3 times; culturing in a 28 ℃ water-proof constant temperature incubator for 24 hours, and observing the result.
And (3) result judgment: the diameter of the bacteria growth zone is measured by a ruler by taking a bacteria growth zone which is not visible to naked eyes around the oxford cup as the bacteria inhibition zone, and the average value of 3 measurement results is taken as the bacteria inhibition zone of the compound to staphylococcus aureus. The diameter of the inhibition zone is expressed as d, and when d is less than 10mm, the inhibition zone is drug resistance (R); when d is more than or equal to 10 and less than or equal to 15, the sensor is moderately sensitive (I); when d >15mm, is highly sensitive (S).
Table 7 8 in vitro antibacterial test of Methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester against Staphylococcus aureus
| Application example | Compounds of formula (I) | Average inhibition zone diameter/mm | Sensitivity to |
| 1 | 8-Methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester | 22 | S |
Table 7 shows that 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester has good inhibitory effect on Staphylococcus aureus, and can be used as Staphylococcus aureus inhibitor.
Claims (3)
1. A method for synthesizing 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester on line by lipase catalysis is characterized by comprising the following steps:
uniformly filling lipase RM IM in a reaction channel of a microfluidic channel reactor, dissolving 8-methoxycoumarin-3-carboxylic acid methyl ester and D-glucose respectively by using a reaction solvent, respectively injecting the dissolved 8-methoxycoumarin-3-carboxylic acid methyl ester and D-glucose into a pipeline through a first injector and a second injector for integration, then entering the reaction channel for reaction, controlling the reaction temperature to be 30-60 ℃, controlling the continuous flowing reaction time of mixed solution in the reaction channel to be 10-60 min, collecting the reaction solution flowing out of the reaction channel on line through a product collector, and performing aftertreatment to obtain a product 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester (I);
the reaction solvent is a mixed solvent of dimethyl sulfoxide and tertiary amyl alcohol, wherein the volume ratio of dimethyl sulfoxide to tertiary amyl alcohol is 1: 8-20;
the ratio of the amounts of the substances of 8-methoxy coumarin-3-carboxylic acid methyl ester and D-glucose in the mixed solution entering the reaction channel is 1:0.2 to 3;
the post-treatment method comprises the following steps: the solvent was removed by distillation under reduced pressure from the reaction mixture, and the mixture was subjected to column chromatography on a silica gel column, and the column was packed with 200-300 mesh silica gel by wet method, with the volume ratio of dichloromethane and methanol=10: 1.5, collecting the eluent containing the target compound by TLC tracking the elution process, evaporating the solvent and drying to obtain the product 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester (I);
2. the method for synthesizing 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester on line by lipase catalysis according to claim 1, wherein after the 8-methoxycoumarin-3-carboxylic acid methyl ester and the D-glucose are respectively dissolved by a reaction solvent, the ratio of the mass concentration of the obtained 8-methoxycoumarin-3-carboxylic acid methyl ester solution to the mass concentration of the D-glucose solution is 1:0.2 to 3; the flow rates of the 8-methoxycoumarin-3-carboxylic acid methyl ester solution and the D-glucose solution are the same when the 8-methoxycoumarin-3-carboxylic acid methyl ester solution and the D-glucose solution are injected through a first injector and a second injector respectively.
3. The method for synthesizing 8-methoxycoumarin-3-carboxylic acid-6' -O-D-glucose ester on line by lipase catalysis according to claim 1, wherein the catalyst lipase RM IM is added in an amount of 0.025-0.05 g/mL based on the volume of the reaction medium.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010132118.5A CN111411137B (en) | 2020-02-29 | 2020-02-29 | Method for synthesizing 8-methoxyl coumarin-3-carboxylic acid-6' -O-D-glucose ester on line under catalysis of lipase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010132118.5A CN111411137B (en) | 2020-02-29 | 2020-02-29 | Method for synthesizing 8-methoxyl coumarin-3-carboxylic acid-6' -O-D-glucose ester on line under catalysis of lipase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111411137A CN111411137A (en) | 2020-07-14 |
| CN111411137B true CN111411137B (en) | 2023-04-25 |
Family
ID=71488978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010132118.5A Active CN111411137B (en) | 2020-02-29 | 2020-02-29 | Method for synthesizing 8-methoxyl coumarin-3-carboxylic acid-6' -O-D-glucose ester on line under catalysis of lipase |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111411137B (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101613388A (en) * | 2009-07-16 | 2009-12-30 | 中国科学院大连化学物理研究所 | The coumarin kind compound of glucuronidation and application thereof |
| CN102887914A (en) * | 2012-10-17 | 2013-01-23 | 华东理工大学 | Coumarins compound containing aryl boric acid and application thereof in detection of sugar |
| CN103965268A (en) * | 2014-05-20 | 2014-08-06 | 河北中烟工业有限责任公司 | Preparation method and application of 8-methoxycoumarin-3-glucose ester formate |
| CN107158050A (en) * | 2016-03-15 | 2017-09-15 | 中国医学科学院药物研究所 | Hydrangea paniculata general coumarin glycosides, its preparation method and combinations thereof and purposes |
| CN109705177A (en) * | 2018-12-24 | 2019-05-03 | 郑州安图生物工程股份有限公司 | A kind of substrate and its preparation method and application |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106459126B (en) * | 2014-04-08 | 2019-10-01 | 国立大学法人弘前大学 | Novel grape sugar derivatives and the cell imaging method and imaging agent for using the derivative |
-
2020
- 2020-02-29 CN CN202010132118.5A patent/CN111411137B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101613388A (en) * | 2009-07-16 | 2009-12-30 | 中国科学院大连化学物理研究所 | The coumarin kind compound of glucuronidation and application thereof |
| CN102887914A (en) * | 2012-10-17 | 2013-01-23 | 华东理工大学 | Coumarins compound containing aryl boric acid and application thereof in detection of sugar |
| CN103965268A (en) * | 2014-05-20 | 2014-08-06 | 河北中烟工业有限责任公司 | Preparation method and application of 8-methoxycoumarin-3-glucose ester formate |
| CN107158050A (en) * | 2016-03-15 | 2017-09-15 | 中国医学科学院药物研究所 | Hydrangea paniculata general coumarin glycosides, its preparation method and combinations thereof and purposes |
| CN109705177A (en) * | 2018-12-24 | 2019-05-03 | 郑州安图生物工程股份有限公司 | A kind of substrate and its preparation method and application |
Non-Patent Citations (1)
| Title |
|---|
| Li-Hua Du et al..A sustainable innovation for the tandem synthesis of sugar-containing coumarin derivatives catalyzed by lipozyme TL IM from Thermomyces lanuginosus in continuous-flow microreactors.《catalysts》.2020,第10卷第13252–13259页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111411137A (en) | 2020-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107384991B (en) | Method for synthesizing 5' -O-ethylene adipamide uridine on line by lipase catalysis | |
| Vic et al. | Enzymatic glucosylation of hydrophobic alcohols in organic medium by the reverse hydrolysis reaction using almond‐β‐D‐glucosidase | |
| CN109988794B (en) | Method for synthesizing nitrobenzimidazole derivatives through enzyme catalysis in continuous flow reactor | |
| CN109593804B (en) | Method for quickly synthesizing nitrobenzimidazole derivative through enzyme catalysis | |
| CN109735582B (en) | Method for synthesizing cyclohexanol beta-amino alcohol derivatives on line by lipase catalysis | |
| CN103667402A (en) | Method for synthesizing 6''-O-lauroyl-naringin ester on line by using lipase as catalyst | |
| CN103509816B (en) | Produce the construction process of Coenzyme Q10 99.0 engineering bacteria, engineering bacteria and application thereof | |
| CN103667396A (en) | Method for synthesizing 6''-O-lauroyl-naringin dihydrochalcone ester on line by using lipase as catalyst | |
| CN107384781A (en) | A kind of method of lipase-catalyzed online synthesis 5 '-O- ethene adipyls -5-methyl-uridin | |
| CN107384992A (en) | A kind of method of lipase-catalyzed online synthesis 5 '-O- lauroyl -5-methyl-uridin | |
| Du et al. | Microfluidic reactor for lipase-catalyzed regioselective synthesis of neohesperidin ester derivatives and their antimicrobial activity research | |
| CN111455004B (en) | Method for synthesizing coumarin-3-carboxylic acid-6' -O-D-mannose ester on line by lipase catalysis | |
| CN111560408B (en) | Method for synthesizing coumarin-3-carboxylic acid sugar ester derivative on line based on flow chemistry enzymatic catalysis | |
| CN107488690A (en) | A kind of method of lipase-catalyzed online synthesis N (5 glucose ester valeryl) mexiletine | |
| CN111411137B (en) | Method for synthesizing 8-methoxyl coumarin-3-carboxylic acid-6' -O-D-glucose ester on line under catalysis of lipase | |
| CN111455005B (en) | Method for synthesizing coumarin-3-carboxylic acid-6' -O-D-sucrose ester derivative on line enzymatically based on flow chemistry | |
| CN109988787B (en) | Method for synthesizing 2-phenylamino cyclohexanol on line under catalysis of lipase | |
| CN109706194B (en) | Method for synthesizing phenethyl alcohol beta-amino alcohol derivatives on line based on mobile chemical enzymatic ammonolysis reaction | |
| CN111690698A (en) | Method for synthesizing 3- (benzo [ d ] [1,3] dioxo-5-amino) propyl hydroxamic acid by two-step serial flow | |
| WO2023083226A1 (en) | α-SALIDROSIDE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | |
| CN103667393A (en) | Method for synthesizing 6''-O-palmitoyl-neohesperidin dihydrochalcone ester on line by using lipase as catalyst | |
| CN109762853B (en) | Method for synthesizing isopropanol beta-alkamine derivative on line by lipase catalysis | |
| CN103667394A (en) | Method for synthesizing 6''-O-lauroyl-neohesperidin dihydrochalcone ester on line by using lipase as catalyst | |
| CN111690695A (en) | Enzymatic microfluidic online synthesis method of 3-phenylaminopropylhydroxamic acid | |
| Li et al. | Dependence of catalytic performance of a freeze-dried whole-cell biocatalyst of Pseudomonas fluorescens in regioselective acetylation of 1-β-d-arabinofuranosylcytosine on growth conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |